TY  - GEN
AU  - Montero, Maria M
AU  - Domene Ochoa, Sandra
AU  - López-Causapé, Carla
AU  - Luque, Sonia
AU  - Sorli, Luisa
AU  - Campillo, Nuria
AU  - Lopez Montesinos, Inmaculada
AU  - Padilla, Eduardo
AU  - Prim, Nuria
AU  - Angulo-Brunet, Ariadna
AU  - Grau, Santiago
AU  - Oliver, Antonio
AU  - Horcajada, Juan P
PY  - 2021
DO  - 10.1128/Spectrum.00585-21
SN  - 2165-0497
UR  - https://hdl.handle.net/20.500.12105/23136
AB  - Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective of our study was to perform a...
LA  - eng
PB  - American Society for Microbiology (ASM)
KW  - Ceftazidime-avibactam
KW  - Colistin
KW  - Aztreonam
KW  - Amikacin
KW  - Combination therapy
KW  - Pseudomonas aeruginosa
KW  - Drug Combinations
KW  - Drug Resistance, Multiple, Bacterial
KW  - Anti-Bacterial Agents
KW  - Microbial Sensitivity Tests
KW  - Ceftazidime
KW  - Azabicyclo Compounds
KW  - Humans
KW  - Kinetics
KW  - Pseudomonas aeruginosa
KW  - Pseudomonas Infections
TI  - Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates
TY  - research article
ER  -